<div class="entities" style="line-height: 2.5; direction: ltr">Admission Date:  [**2207-8-16**]              Discharge Date:   [**2207-9-2**]<br><br>Date of Birth:  [**2150-9-2**]             Sex:   M<br><br>Service: SURGERY<br><br>Allergies:<br>No Known Allergies / Adverse Drug Reactions<br><br>Attending:[**First Name3 (LF) 1234**]<br>Chief Complaint:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Severe
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    lower
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    extremity
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    lymphedema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with superimposed cellulitis<br><br>Major Surgical or Invasive Procedure:<br>[**2207-8-24**]:Left below-knee amputation (circular 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    guillotine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
).<br>[**2207-8-28**]: Re-amputation and closure of left below-knee<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    amputation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br><br><br>History of Present Illness:<br>56yo male with a history of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    DM2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    CAD
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 s/p 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    CABG
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, peripheral<br>vascular disease, and prior history of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    chronic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    lymphedema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 was<br>admitted on [**2207-8-16**] for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    LLE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    cellulitis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  His left lower<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    extremity
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    lymphedema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 started after vascular surgery in [**2205**] (L<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    SFA
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    anterior
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    tibial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    bypass
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 graft).  Left leg is extremely<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    painful
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. More recently he has been on his feet more, which has<br>been causing worsening 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    edema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. He has occasional serous<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    drainage
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 from left leg.  He was admitted to the hospital for<br>aggressive treatment of his 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    lymphedema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and broad spectrum<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br><br><br>Past Medical History:<br>PMH: CAD  CHF (EF45%), DM2, 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    psoriatic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    arthitis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
, PAD, chronic BLE<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    lymphedema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 (L&gt;R)<br>PSH: CABGx5 '[**97**], PCI '[**98**] and '[**05**], L 5th ray amp, L SFA-AT RSVG,<br>L 5th ray amp site 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    debridement
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br><br><br>Social History:<br>Previously worked as consultant, currently on disability.<br>Single, lives with sister who is bipolar and reportedly refuses<br>to allow 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    VNA
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 into house.<br>- Tobacco history: former, quit &gt; 10 yrs ago. 40+ pack yr hx<br>- ETOH: occasional<br>- Illicit drugs: denies<br><br><br>Physical Exam:<br>Alert and oriented x 3<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    VS
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
:BP 130/70    HR  90<br>Resp: Lungs clear<br>Abd: Soft, non tender<br>Ext: Pulses:      Left  Femoral palp,<br>                  Right Femoral palp,    DP 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    dop
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
  ,PT 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    dop
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>Right foot warm,  well perfused.  No open areas<br>Left 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    BKA
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 Incision: clean and dry.  No reddness, drainage.<br><br>Pertinent Results:<br>[**2207-9-2**] 05:10AM BLOOD WBC-12.2* RBC-3.10* Hgb-8.7* Hct-27.6*<br>MCV-89 MCH-28.2 MCHC-31.7 RDW-17.8* Plt Ct-321<br>[**2207-9-2**] 05:10AM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    UreaN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-32* Creat-1.3* Na-140 K-4.3 Cl-104<br>HCO3-26 AnGap-14<br>[**2207-9-2**] 05:10AM BLOOD 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Calcium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-8.8 Phos-3.2 Mg-1.8<br><br>                            **FINAL REPORT [**2207-9-2**]**<br><br>   C
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    difficile
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    DNA
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 amplification assay (Final [**2207-9-2**]):<br>      Negative for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    toxigenic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    C
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    difficile
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 by the 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Illumigene
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 DNA<br>      amplification assay.<br>           (Reference Range-Negative).<br><br><br><br><br>Brief Hospital Course:<br>56 year old man with a history of chronic L&gt;R painful lymphedema<br>was admitted to the hospital on [**2207-8-16**] with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    severe
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    cellulitis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>which we treated with aggressive 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    ACE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 wrap and elevation, 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    diuresis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. Despite 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 (
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    vanco
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    cipro
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
,<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    flagyl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    zosyn
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
) his WBC continues to rise with low grade<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    temps
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.   He also developed a new 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    erythema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    over
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    trunk
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>
 so ID was<br>consulted on [**2207-8-20**]. His 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 were discontinued and he<br>was started on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    ceftaroline
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.  His 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    cellulitis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    rash
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 slowly<br>improved though his unremitting 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 in his LLE continued to<br>persist. After discussion with palliative care, 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    chronic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>services and Dr. [**Last Name (STitle) **], the decision was made to go forward<br>with a Left BKA to improve Mr. [**Known lastname 36515**] quality of life which<br>was performed (
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    guillotine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
) on [**2207-8-23**].  At this point, his<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    antibiotic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was then changed to 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Linezolid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.  He returned to the OR<br>on [**2207-8-28**] for Re-amputation and closure of left below-knee<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    amputation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  Post operatively in the PACU, he required a brief<br>reintubation secondary to hypoxia. His CXR was consistent with<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pulmonary
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    edema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  He was monitored overnight in the CVICU then<br>transferred to the floor.<br><br>On the floor, he has made steady progress. He has remained<br>afebrile with baseline renal function and hemodynamically<br>stable.  He has worked with PT who recommended rehab.<br>In terms of his medications:<br>- We weaned his 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    oxycontin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 from 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    40mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 to 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    30mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 on [**2207-9-1**].<br> He is due to have it decreased again on [**2207-9-3**]. Since the BKA<br>he has had minimal 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>- He was restarted on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 on [**2207-9-1**] secondary to his<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with [**Country **] score of 3.<br>- We did not restart  
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Moexipril
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    30
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    twice
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 secondary to<br>ongoing aggressive 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    diuresis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and borderline renal function.<br>- He will continue on the 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    linezolid
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 until his postop check on<br>next week.<br><br>Medications on Admission:<br> 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    ASA325
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Amlodipine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    10
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Carvedilol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    25
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 [**Hospital1 **], 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Clobestasol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    qAM
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
,<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Furosemide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    40
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
'', 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Glipizide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Moexipril
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 30'', 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Rosuvastatin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
,<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    oxycontin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    20
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
''.<br><br><br>Discharge Medications:<br>1. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Rosuvastatin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Calcium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>2. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Warfarin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    ONCE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 Duration: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 Doses<br>3. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    GlipiZIDE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>4. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Clobetasol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Propionate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    05
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    %
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Cream
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Appl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    TP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 [**Hospital1 **]<br>5. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Carvedilol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    25
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    BID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>6. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Amlodipine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    10
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>7. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Aspirin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    325
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>8. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Furosemide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    40
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    BID
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br><br><br>Discharge Disposition:<br>Extended Care<br><br>Facility:<br>[**Hospital3 1107**] [**Hospital **] [**Hospital 1108**] Rehab Unit at<br>[**Hospital6 1109**] - [**Location (un) 1110**]<br><br>Discharge Diagnosis:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Lymphedema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with superimposed 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    cellulitis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and unremitting pain<br>left foot<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Peripheral
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Arterial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Venostasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br><br><br>Discharge Condition:<br>Mental Status: Clear and coherent.<br>Level of Consciousness: Alert and interactive.<br>Activity Status: Out of Bed with assistance to chair or<br>wheelchair.<br><br><br>Discharge Instructions:<br>You were admitted to the hospital with worsening left lower<br>extremity 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    swelling
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, infection and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    unremitting
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Despite<br>aggressive treatment of your 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    venostasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, profound 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    lymphedema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    elephantiasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    arterial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    ischemia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 we were unable to<br>adequately control your 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  It was decided that a below-knee<br>amputation was the best course of action.<br><br>DISCHARGE INSTRUCTIONS FOLLOWING  AMPUTATION<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    ACTIVITY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: There are restrictions on activity. On the side of<br>your amputation you are non weight bearing for 4-6 weeks. You<br>should keep this 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    amputation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 site elevated when ever possible.<br>Avoid any pressure to your 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    amputation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    site
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br><br>You may use the opposite foot for transfers and pivots.<br>No driving until cleared by your Surgeon.<br><br>PLEASE CALL US IMMEDIATELY FOR ANY OF THE FOLLOWING PROBLEMS:<br>Redness in or drainage from your leg wound(s).<br>New pain, numbness or discoloration of your foot or toes.<br><br>Exercise:Limit strenuous activity 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    for
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    6
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    weeks
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
. No heavy lifting<br>greater than 20 pounds for the next 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Duration</span>
</mark>
 weeks. Try to keep leg<br>elevated when able.<br><br>BATHING/SHOWERING:<br>You may shower immediately upon coming home. No baths or<br>swimming. You may leave your incision open to air. Wash your<br>incision(s) gently with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    soap
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    water
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. You will have sutures,<br>which are usually removed in 4 weeks.<br><br>WOUND 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    CARE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
:<br>Keep your wound clean and dry. If there is any drainage cover<br>with a dry sterile gauze and let your doctor know.<br><br>MEDICATIONS:<br>We started you on a new medication called 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    prevent
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    blood
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    clots
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    from
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 your 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  Dr. [**Last Name (STitle) 36516**], your PCP,<br>[**Name10 (NameIs) **] monitor your INRs and adjust your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 dose 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>Unless told otherwise you should resume taking all of the<br>medications you were taking before surgery. You will be given a<br>new prescription for 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    medication
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 to be taken if necessary.<br><br>We restarted your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 on [**2207-9-1**].  Your PCP will manage<br>your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 when you are discharged to home.  We have also<br>decreased your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    medications
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
.  You were taking 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    20mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    twice
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
<br>daily of 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    oxycontin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 prior to admission.  On [**2207-9-1**], we decreased<br>you 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    oxycontin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    20mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    in
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    the
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    AM
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 and 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    10mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    at
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    night
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.  They will<br>continue to wean this medication at rehab as tolerated.<br><br><br><br><br><br>You were admitted to the hospital with worsening left lower<br>extremity 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    swelling
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
, infection and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    unremitting
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Despite<br>aggressive treatment of your 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    venostasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, profound 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    lymphedema
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
<br>with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    elephantiasis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
, and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    arterial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    ischemia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 we were unable to<br>adequately control your 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  It was decided that a below-knee<br>amputation was the best course of action.<br><br>DISCHARGE INSTRUCTIONS FOLLOWING  AMPUTATION<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    ACTIVITY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: There are restrictions on activity. On the side of<br>your amputation you are non weight bearing for 4-6 weeks. You<br>should keep this 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    amputation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 site elevated when ever possible.<br>Avoid any pressure to your 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    amputation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    site
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br><br>You may use the opposite foot for transfers and pivots.<br>No driving until cleared by your Surgeon.<br><br>PLEASE CALL US IMMEDIATELY FOR ANY OF THE FOLLOWING PROBLEMS:<br>Redness in or drainage from your leg wound(s).<br>New pain, numbness or discoloration of your foot or toes.<br><br>Exercise:Limit strenuous activity 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    for
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    6
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    weeks
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
. No heavy lifting<br>greater than 20 pounds for the next 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Duration</span>
</mark>
 weeks. Try to keep leg<br>elevated when able.<br><br>BATHING/SHOWERING:<br>You may shower immediately upon coming home. No baths or<br>swimming. You may leave your incision open to air. Wash your<br>incision(s) gently with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    soap
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    water
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. You will have sutures,<br>which are usually removed in 4 weeks.<br><br>WOUND 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    CARE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
:<br>Keep your wound clean and dry. If there is any drainage cover<br>with a dry sterile gauze and let your doctor know.<br><br>MEDICATIONS:<br>We started you on a new medication called 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    prevent
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    blood
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    clots
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    from
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 your 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    atrial
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    fibrillation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  Dr. [**Last Name (STitle) 36516**], your PCP,<br>[**Name10 (NameIs) **] monitor your INRs and adjust your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 dose 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>Unless told otherwise you should resume taking all of the<br>medications you were taking before surgery. You will be given a<br>new prescription for 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    medication
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 to be taken if necessary.<br><br>We restarted your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 on [**2207-9-1**].  Your PCP will manage<br>your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    coumadin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 when you are discharged to home.  We have also<br>decreased your 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    pain
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    medications
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
.  You were taking 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    20mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    twice
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
<br>daily of 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    oxycontin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 prior to admission.  On [**2207-9-1**], we decreased<br>you 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    oxycontin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    20mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    in
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    the
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    AM
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
 and 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    10mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    at
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    night
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.  They will<br>continue to wean this medication at rehab as tolerated.<br><br><br><br><br><br><br>Followup Instructions:<br>Department: VASCULAR SURGERY<br>When: WEDNESDAY [**2207-9-9**] at 11:00 AM<br>With:  [**Hospital 21926**] CLINIC [**Telephone/Fax (1) 1237**]<br>Building: LM [**Hospital Ward Name **] 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em;">
    Bldg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 ([**Last Name (NamePattern1) **]) [**Location (un) **]<br>Campus: WEST     Best Parking: [**Hospital Ward Name **] Garage<br><br>Department: VASCULAR SURGERY<br>When: TUESDAY [**2207-9-29**] at 1 PM<br>With: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 1244**], MD [**Telephone/Fax (1) 1237**]<br>Building: LM [**Hospital Unit Name **] [**Location (un) **]<br>Campus: WEST     Best Parking: [**Hospital Ward Name **] Garage<br><br><br><br>Completed by:[**2207-9-2**]</div>